AEON Biopharma Announces Strategic Resource Reprioritization And Cost Reduction Plan; AEON Has Reduced Its Workforce By ~55%
AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex for the treatment of multiple debilitating medical